Skip to main content
Premium Trial:

Request an Annual Quote

Paracel and Lion Partner to Co-Market Integrated BlastMachine/BioScout Product


Lion Bioscience and Celera Genomics’ Paracel division are partnering to integrate Lion’s software with Paracel’s accelerated bioinformatics hardware, the companies told BioInform last week.

The companies have nearly completed the integration of Lion’s BioScout sequence analysis and characterization software with BlastMachine and are ready to release the combined product to customers, said Shi-Ping Hsu, general manager of Paracel.

The project is the first in a series of integration projects that Paracel is planning with other bioinformatics software providers, said Joe Borkowski, Paracel’s director of marketing.

The companies have agreed to co-market each other’s products as part of the deal. Financial details were not disclosed.

BioScout currently relies on Blast as part of its analysis pipeline, but the unmodified Blast algorithm currently slows the process considerably, Lion said. By integrating the accelerated BlastMachine system into the software, BioScout customers who have Paracel equipment will see a significant speed-up in the analysis process, according to the companies.

Borkowski said the time saving would depend on the type of Paracel system used. Speed scales linearly with the number of processors, he said, which generally range from 16 to 48 but can go higher.

Additionally, database updating and indexing features included in BioScout will manage database resources in the integrated product.

Paracel said Lion approached them after the release of BlastMachine to discuss options to speed the Blast stage of the BioScout pipeline.

The two companies are in talks regarding “other opportunities,” Hsu said, but was unable to disclose further details.

“They have a real product and we do too, so there’s a lot of opportunity there,” Hsu said.

— BT

Filed under

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.